Multiple studies have demonstrated that GLP-1 analogues administration has beneficial effects over HbA1C levels and glucagon serum levels [122,123,124,125], and their insulinotropic and glucagonostatic effects are considered equal contributors in T2DM glycaemic control [126]. This evidence concerns the gene GCG and type 2 diabetes mellitus.